Repeat stereotactic radiotherapy achieved 76% one-year local control for recurrent brain metastases
Across 14 studies, repeat stereotactic radiotherapy achieved 76% one-year local control, but symptomatic radiation necrosis occurred in 10%.
Across 14 studies, repeat stereotactic radiotherapy achieved 76% one-year local control, but symptomatic radiation necrosis occurred in 10%.
With 42.56 Gy in 16 fractions, three-year lymphedema was 6.4%, with no new events through five years.
Bragg peak FLASH achieved high ultra-high-dose-rate coverage with similar target coverage to conventional IMPT, but produced higher target and CNS hotspots.
Ten-year biochemical control was 64.7% after salvage proton therapy, with 3.2% late grade 3 genitourinary toxicity.
Patients >70 receiving 66 Gy with daily low-dose cisplatin had survival and severe toxicity similar to younger patients in this retrospective cohort.
Maximum cardiac avoidance area dose below 43.5 Gy was associated with longer median survival after curative-intent oesophageal radiotherapy.
In de novo metastatic HNSCC, locoregional radiotherapy and first-line immunotherapy were independently associated with longer overall survival.
Ten years after radiotherapy, 35% of long-term head and neck cancer survivors had trismus with persistently worse quality of life.
Median restenosis-free interval increased from 96 to 350 days after intravascular brachytherapy for repeatedly recurrent coronary in-stent restenosis.
A multidisciplinary roadmap defines the safety, imaging and research requirements needed before upright radiotherapy can be adopted more broadly in children.
Patients aged ≥70 had similar recurrence outcomes after definitive chemoradiotherapy despite inferior overall survival and greater competing mortality.
Grade ≥3 mucositis at week 6 occurred in 11.1% with benzydamine versus 70.6% with standard care.
In 93 glioma cases, a five-parameter CTV model reproduced physician contours and achieved similar blinded clinical quality ratings.
IBTVG experts defined reproducible CT-based GTV, CTV and PTV concepts for common tendinitis and bursitis sites treated with low-dose radiotherapy.
A decade after the previous IAEA survey, access to modern paediatric radiotherapy improved, but substantial technology, imaging and workforce disparities remain.